<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Research on BEHIND-MS</title>
    <link>https://www.behind-ms.eu/en/tags/research/</link>
    <description>Recent content in Research on BEHIND-MS</description>
    <generator>Hugo</generator>
    <language>en</language>
    <lastBuildDate>Tue, 17 Nov 2026 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.behind-ms.eu/en/tags/research/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>BEHIND-MS Annual Meeting - 2026</title>
      <link>https://www.behind-ms.eu/en/news/annual-meeting-2026/</link>
      <pubDate>Tue, 17 Nov 2026 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/annual-meeting-2026/</guid>
      <description>&lt;h1 id=&#34;a-shared-spirit-of-collaboration-in-heidelberg&#34;&gt;A shared spirit of collaboration in Heidelberg&lt;/h1&gt;&#xA;&lt;p&gt;&lt;em&gt;Two days of lively discussion, project progress and stronger connections across the consortium.&lt;/em&gt;&lt;/p&gt;&#xA;&lt;p&gt;On 2 and 3 November, the BEHIND-MS consortium came together in Heidelberg for its annual meeting. It was an opportunity to reconnect, reflect on the project’s progress and exchange ideas. Across the two days, one theme stood out: a strong sense of shared purpose and collaboration.&lt;/p&gt;&#xA;&lt;h2 id=&#34;progress-through-open-exchange&#34;&gt;Progress through open exchange&lt;/h2&gt;&#xA;&lt;p&gt;The meeting reflected the strong progress being made across the BEHIND-MS project. Presentations prompted many questions and thoughtful discussions, giving consortium members the chance to exchange perspectives and explore the work together. The conversations following the talks were an important part of the meeting, bringing colleagues into dialogue around the project’s ongoing work.&lt;/p&gt;</description>
    </item>
    <item>
      <title>BEHIND-MS at ECTRIMS 2026</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2026/</link>
      <pubDate>Tue, 10 Nov 2026 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2026/</guid>
      <description>&lt;h1 id=&#34;behind-ms-at-ectrims-2026&#34;&gt;BEHIND-MS at ECTRIMS 2026:&lt;/h1&gt;&#xA;&lt;h2 id=&#34;can-understanding-ebv-help-us-move-towards-ms-prevention&#34;&gt;Can understanding EBV help us move towards MS prevention?&lt;/h2&gt;&#xA;&lt;p&gt;At ECTRIMS 2026, the session “&lt;em&gt;Towards MS prevention&lt;/em&gt;” explored an increasingly important question: if we better understand what happens before multiple sclerosis develops, could we eventually intervene earlier, or even prevent it?&lt;/p&gt;&#xA;&lt;p&gt;As part of the session, Prof. Christian Münz presented research from the BEHIND-MS project, providing new insights into how Epstein-Barr virus (EBV) could contribute to inflammation and damage in the central nervous system.&lt;/p&gt;</description>
    </item>
    <item>
      <title>European Academy of Neurology 2026</title>
      <link>https://www.behind-ms.eu/en/news/ean26/</link>
      <pubDate>Tue, 18 Aug 2026 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ean26/</guid>
      <description>&lt;p&gt;The link between the Epstein–Barr virus (EBV) and multiple sclerosis (MS) has become increasingly clear over the past decade. Today, EBV is widely considered a prerequisite for the development of MS, with elevated immune responses against the virus detectable many years before the first clinical symptoms appear. In particular, antibodies targeting the Epstein–Barr nuclear antigen 1 (EBNA1) have consistently been associated with an increased risk of developing the disease. However, while the quantity of these antibodies has been well studied, far less is known about how they function and whether they actively contribute to disease processes.&lt;/p&gt;</description>
    </item>
    <item>
      <title>BEHIND-MS Annual Meeting 2025</title>
      <link>https://www.behind-ms.eu/en/news/2025-11-12/</link>
      <pubDate>Wed, 12 Nov 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/2025-11-12/</guid>
      <description>&lt;h2 id=&#34;behind-ms-annual-meeting-2025-advancing-research-on-epstein-barr-virus-and-multiple-sclerosis&#34;&gt;BEHIND-MS Annual Meeting 2025: Advancing Research on Epstein-Barr Virus and Multiple Sclerosis&lt;/h2&gt;&#xA;&lt;p&gt;From 10–11 November 2025, partners of the BEHIND-MS project gathered in Heidelberg, Germany, for the annual consortium meeting, hosted at the German Cancer Research Center (DKFZ). The meeting brought together leading scientists, clinicians, and patient engagement experts from across Europe to discuss the project’s progress and next steps in uncovering the complex links between Epstein-Barr virus (EBV) infection and multiple sclerosis (MS).&lt;/p&gt;</description>
    </item>
    <item>
      <title>BEHIND-MS at ECTRIMS 2025</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2025-au/</link>
      <pubDate>Tue, 28 Oct 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2025-au/</guid>
      <description>&lt;p&gt;At this year’s &lt;a href=&#34;https://ectrims.eu/ectrims2025/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;ECTRIMS Congress&lt;/a&gt;&#xA; in Barcelona (24–26 September 2025), the EU Horizon-funded consortia &lt;a href=&#34;https://www.behind-ms.eu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;BEHIND-MS&lt;/a&gt;&#xA; made a powerful contribution to advancing our understanding of the Epstein-Barr virus (EBV) and its potential role in multiple sclerosis (MS). Through a series of oral and poster presentations, educational sessions, and collaborative meetings, BEHIND-MS researchers shared groundbreaking findings that shed light on how EBV infection, immune dysregulation, and genetic susceptibility intersect in MS.&#xA;The consortium’s strong presence at ECTRIMS highlighted not only scientific excellence but also the importance of collaboration across Europe to accelerate discovery and move closer to prevention and better outcomes for people with MS.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Breaking Ground on EBV and MS</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2025-bg/</link>
      <pubDate>Tue, 28 Oct 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2025-bg/</guid>
      <description>&lt;p&gt;At this year’s &lt;a href=&#34;https://ectrims.eu/ectrims2025/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;ECTRIMS Congress&lt;/a&gt;&#xA; in Barcelona (24–26 September 2025), the EU Horizon-funded consortia &lt;a href=&#34;https://www.behind-ms.eu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;BEHIND-MS&lt;/a&gt;&#xA; and &lt;a href=&#34;https://www4.uib.no/en/research/research-projects/ebv-ms&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;EBV-MS&lt;/a&gt;&#xA; joined forces to host a highly engaging educational session titled: &lt;em&gt;“Epstein-Barr Virus in Multiple Sclerosis: Where are we? Where should we go?”&lt;/em&gt;&lt;/p&gt;&#xA;&lt;p&gt;The session explored the emerging evidence on the role of Epstein-Barr virus (EBV) in multiple sclerosis (MS) and examined how this knowledge could guide future prevention and treatment strategies.&lt;/p&gt;&#xA;&lt;p&gt;The session was chaired by &lt;strong&gt;Prof. Jan Lünemann&lt;/strong&gt; (University of Münster, BEHIND-MS consortium), &lt;strong&gt;Prof. Marianna Cortese&lt;/strong&gt; (Harvard T.H. Chan School of Public Health in Boston, EBV-MS consortium), and &lt;strong&gt;Prof. Øivind Torkildsen&lt;/strong&gt; (University of Bergen, EBV-MS consortium).&lt;/p&gt;</description>
    </item>
    <item>
      <title>Strengthening Scientific Synergies in the BEHIND-MS Consortium</title>
      <link>https://www.behind-ms.eu/en/news/2025-07-16/</link>
      <pubDate>Wed, 16 Jul 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/2025-07-16/</guid>
      <description>&lt;h2 id=&#34;strengthening-scientific-synergies-in-the-behind-ms-consortium-partner-visits-in-zurich-and-rotterdam&#34;&gt;Strengthening Scientific Synergies in the BEHIND-MS Consortium: Partner Visits in Zurich and Rotterdam&lt;/h2&gt;&#xA;&lt;p&gt;In collaborative research, face-to-face interactions often bring an added dimension of depth and momentum that emails and online meetings cannot fully replace. Within the BEHIND-MS consortium, recent exchange visits between partners have reinforced the value of close coordination, shared learning, and mutual inspiration across institutions.&lt;/p&gt;&#xA;&lt;p&gt;This year, two key visits took place between partners leading Work Packages 2 and 4 of the BEHIND-MS project: the University of Zurich’s Institute of Experimental Immunology, co-directed by &lt;strong&gt;Prof. Christian Münz&lt;/strong&gt;, and the MS Center ErasMS at Erasmus MC, led by &lt;strong&gt;Prof. Marvin van Luijn&lt;/strong&gt;.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Mystery Solved Project 2025</title>
      <link>https://www.behind-ms.eu/en/news/2025-05-26/</link>
      <pubDate>Mon, 26 May 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/2025-05-26/</guid>
      <description>&lt;h2 id=&#34;mystery-solved-project-2025-advancing-the-understanding-of-ebv-and-ms&#34;&gt;Mystery Solved Project 2025: Advancing the Understanding of EBV and MS&lt;/h2&gt;&#xA;&lt;p&gt;On 23–24 May 2025, the &lt;a href=&#34;https://www.charcot-ms.org/about&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;European Charcot Foundation&lt;/a&gt;&#xA; and the &lt;a href=&#34;https://www.charcot-ms.org/conferences/mystery-solved-project-2025&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Mystery Solved Project (MSP)&lt;/a&gt;&#xA; hosted a high-level virtual conference bringing together global experts in multiple sclerosis (MS), Epstein-Barr virus (EBV), and immunology. This landmark event offered a unique platform for interdisciplinary exchange, exploring the complex interplay between viral infection, immune system dysfunction, and neurodegenerative disease.&#xA;&lt;img src=&#34;https://www.behind-ms.eu/en/news/2025-05-26/img/MysterySolved2025-600x410.jpg&#34; alt=&#34;Search for EBV&#34;&gt;&lt;/p&gt;&#xA;&lt;h3 id=&#34;the-role-of-epstein-barr-virus-in-multiple-sclerosis&#34;&gt;The Role of Epstein-Barr Virus in Multiple Sclerosis&lt;/h3&gt;&#xA;&lt;p&gt;Recent scientific breakthroughs have increasingly pointed to EBV as a key environmental factor in the development and progression of MS. The virus’s capacity to infect B cells and evade immune surveillance has placed it at the center of neuroimmunological research, particularly for its suspected role in initiating autoimmune processes targeting the central nervous system (CNS).&lt;/p&gt;</description>
    </item>
    <item>
      <title>Engaging Young Researchers</title>
      <link>https://www.behind-ms.eu/en/news/engagingyoungresearchers/</link>
      <pubDate>Fri, 16 May 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/engagingyoungresearchers/</guid>
      <description>&lt;p&gt;At the heart of the BEHIND-MS project is an innovative collaboration involving young researchers and students, whose contributions are playing a crucial role in advancing our understanding of multiple sclerosis (MS). The project&amp;rsquo;s commitment to involving young minds is shaping the future of MS research, allowing for new ideas, fresh perspectives, and cutting-edge technologies to be integrated into this critical field.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Here&amp;rsquo;s how the BEHIND-MS project is engaging young researchers and inspiring the next generation of scientific leaders.&lt;/strong&gt;&lt;/p&gt;</description>
    </item>
    <item>
      <title>Educational Session at ECTRIMS 2025</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2025/</link>
      <pubDate>Tue, 06 May 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2025/</guid>
      <description>&lt;p&gt;We are excited that this year’s ECTRIMS congress, taking place in Barcelona from the September 24-26, will feature an educational session on the &lt;strong&gt;“Epstein Barr-Virus in Multiple Sclerosis: Where are we? Where should we go?”&lt;/strong&gt; chaired by Dr. Jan Lünemann from Münster and Dr. Marianna Cortese from Boston. This educational session will take place September 24 from 8:30 to 9:30 am and will be a joint initiative between &lt;a href=&#34;https://www.behind-ms.eu/en&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;the BEHIND-MS project&lt;/a&gt;&#xA; and &lt;a href=&#34;https://www.uib.no/en/ebvms&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;the EBV-MS project&lt;/a&gt;&#xA;, two ambitious EU-funded consortia focused on elucidating the role of EBV infection in the onset and progression of MS.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Annual Meeting - 2024</title>
      <link>https://www.behind-ms.eu/en/news/annual-meeting/</link>
      <pubDate>Thu, 28 Nov 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/annual-meeting/</guid>
      <description>&lt;h1 id=&#34;exploring-new-frontiers-in-multiple-sclerosis-research-the-behind-ms-annual-meeting-in-heidelberg&#34;&gt;Exploring New Frontiers in Multiple Sclerosis Research: The BEHIND-MS Annual Meeting in Heidelberg&lt;/h1&gt;&#xA;&lt;p&gt;This week, leading researchers, clinicians, and patient advocates gathered in Heidelberg for the first annual meeting of the &lt;a href=&#34;https://www.behind-ms.eu/en/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;BEHIND-MS project&lt;/a&gt;&#xA;, a groundbreaking EU-funded research initiative. The project is focused on understanding how the Epstein-Barr virus (EBV) could be a critical factor in the development of Multiple Sclerosis (MS). As the world’s most common neuroinflammatory disease, MS affects millions of people globally, and while current therapies can slow its progression, a definitive cure remains elusive. Recent findings, however, suggest a possible connection between EBV infection and MS, potentially transforming the field.&lt;/p&gt;</description>
    </item>
    <item>
      <title>BEHIND-MS partners at ECTRIMS 2024</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2024/</link>
      <pubDate>Thu, 29 Aug 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2024/</guid>
      <description>&lt;h2 id=&#34;ectrims-2024&#34;&gt;ECTRIMS 2024&lt;/h2&gt;&#xA;&lt;p&gt;Our BEHIND-MS partner, Dr. Roberta Magliozzi, will be co-chairing the ‘Scientific Session 9: Barriers and lymphatics of the brain’ at ECTRIMS 2024 - the Congress of the European Committee for Treatment and Research in Multiple Sclerosis.&lt;/p&gt;&#xA;&lt;p&gt;The session will include_&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;A presentation from Dr. Marvin van Luijn, BEHIND-MS partner from Erasmus MC – MS Center ErasMS, on “Breaking barriers: scrutinizing T cells that act at the forefront in people with MS”.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Role of EBV in Autoimmunity and Multiple Sclerosis</title>
      <link>https://www.behind-ms.eu/en/news/2024-08-27/</link>
      <pubDate>Tue, 27 Aug 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/2024-08-27/</guid>
      <description>&lt;h2 id=&#34;new-insights-at-the-3rd-joint-ebv-kshv-international-symposium-a-dive-into-the-role-of-ebv-in-autoimmunity-and-multiple-sclerosis&#34;&gt;New Insights at the 3rd Joint EBV-KSHV International Symposium: A Dive into the Role of EBV in Autoimmunity and Multiple Sclerosis&lt;/h2&gt;&#xA;&lt;p&gt;The 3rd Joint Meeting of the &lt;a href=&#34;https://ebv.ksvirus.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;International Symposium on EBV, KSHV - Related Agents and Diseases&lt;/a&gt;&#xA; was held in Boston from June 29th to July 3rd, 2024. This marked a significant gathering for researchers working on Epstein-Barr Virus (EBV), Kaposi Sarcoma Herpes Virus (KSHV), and other gamma herpesviruses to come together and share their most recent and exciting results. This year’s meeting was also the occasion to celebrate the 60th anniversary of the discovery of EBV and the 40th anniversary of the discovery of KSHV, while also paying tribute to the life and the work of Sir Anthony Epstein, a pioneering virologist who co-discovered EBV and whose legacy continues to inspire the scientific community.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Jan Lünemann visits DKFZ</title>
      <link>https://www.behind-ms.eu/en/news/2024-07-22-jan/</link>
      <pubDate>Mon, 22 Jul 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/2024-07-22-jan/</guid>
      <description>&lt;p&gt;Jan Lünemann, Professor of Neurology at the University Hospital Münster, visited colleagues and collaborators at the DKFZ in Heidelberg on the 24th of May 2024.&lt;/p&gt;&#xA;&lt;p&gt;As a member of the BEHIND-MS consortium, he wanted not only to update his consortium partners and other interested members of the scientific public on his recent work on the role of EBV infection for MS, but also take this opportunity for scientific exchange and strengthening the collaboration links between BEHIND-MS partners.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Background</title>
      <link>https://www.behind-ms.eu/en/news/background/</link>
      <pubDate>Tue, 12 Mar 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/background/</guid>
      <description>&lt;p&gt;As the BEHIND-MS group, we want to &lt;strong&gt;understand&lt;/strong&gt; through this project how EBV leads or&#xA;connects to MS. We have gathered a team of experts to study how the virus interacts with the&#xA;immune system in the blood and brain of people with MS. We will also look at how genes play a&#xA;role in MS. We will be making a model of MS in the laboratory using cells from people with MS,&#xA;which will help us understand how MS works. We will also create a model of early MS in animals&#xA;to help test new treatments.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Research</title>
      <link>https://www.behind-ms.eu/en/news/research/</link>
      <pubDate>Tue, 12 Mar 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/research/</guid>
      <description>&lt;p&gt;The BEHIND-MS project is a joint European research effort whose goal is to unravel the contribution of the Epstein-Barr virus to the pathogenesis of Multiple Sclerosis.&lt;/p&gt;&#xA;&lt;h2 id=&#34;multiple-sclerosis-ms&#34;&gt;Multiple Sclerosis (MS)&lt;/h2&gt;&#xA;&lt;p&gt;is the most frequent neuroinflammatory disease that is typically diagnosed in young adults, most frequently females. Despite new treatments that slow the progression of the disease, patients with MS frequently evolve towards major disability and neurodegeneration.&lt;/p&gt;&#xA;&lt;p&gt;The pathogenesis of MS is controversially debated and remains globally enshrouded in mystery, but the recent discovery that infection with the Epstein-Barr virus (EBV) is a major risk factor for MS development will radically change research avenues in the field.&#xA;&lt;em&gt;The project started 1st of December 2023 with a duration of 5 years.&lt;/em&gt;&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
